UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058468
Receipt number R000066852
Scientific Title A Prospective Study to Evaluate the Preventive Effect of Dual Antiplatelet Therapy Including P2Y12 Inhibitor Loading on Early Motor Deterioration in Acute Noncardioembolic Ischemic Stroke
Date of disclosure of the study information 2025/07/20
Last modified on 2025/07/14 21:08:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Dual Antiplatelet Therapy Including P2Y12 Inhibitor Loading in Preventing Motor Function Deterioration in the Acute Phase of Noncardioembolic Ischemic Stroke

Acronym

Motor Function Preservation with DAPT Including P2Y12 Inhibitor Loading in Acute Noncardioembolic Ischemic Stroke

Scientific Title

A Prospective Study to Evaluate the Preventive Effect of Dual Antiplatelet Therapy Including P2Y12 Inhibitor Loading on Early Motor Deterioration in Acute Noncardioembolic Ischemic Stroke

Scientific Title:Acronym

A Prospective Study on the Prevention of Motor Function Deterioration with DAPT Including P2Y12 Inhibitor Loading in Acute Noncardioembolic Ischemic Stroke

Region

Japan


Condition

Condition

Noncardioembolic Ischemic Stroke

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Motor paralysis represents a significant functional loss in ischemic stroke, leading to impairment in activities of daily living. The objective of this study is to evaluate the preventive effects on motor function deterioration during the acute phase of non-cardioembolic ischemic stroke and to explore the optimal therapeutic approach.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Worsening of motor NIHSS by 1 point or more at 7 days after treatment initiation

Key secondary outcomes

1. Worsening of motor NIHSS by 1 point or more at 21 days after treatment initiation
2. Modified Rankin Scale at 21 days after treatment initiation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients receiving dual antiplatelet therapy including P2Y12 inhibitor loading

Interventions/Control_2

Patients receiving other antiplatelet therapies

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

-Age: 20 to 85 years
-Able to start antiplatelet therapy within 48 hours of onset
-Diagnosed with non-cardioembolic ischemic stroke

Key exclusion criteria

-Cardioembolic stroke
-Atherothrombotic cerebral infarction
-Stroke of undetermined embolic source
-Patients with bleeding diathesis
-Patients contraindicated for antiplatelet therapy
-Patients for whom motor function assessment is difficult (including higher brain dysfunction and consciousness disturbance)

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Mizowaki

Organization

Jyunshin Hospital

Division name

Department of Neurosurgery

Zip code

675-0122

Address

865-1 Befu, Befu-cho, Kakogawa City, Hyogo Prefecture, Japan

TEL

079-437-3555

Email

njapxblj@gmail.com


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Mizowaki

Organization

Junshin Hospital Clinical Research Department

Division name

Clinical Neurosurgery Research Department

Zip code

675-0122

Address

865-1 Befu, Befu-cho, Kakogawa City, Hyogo Prefecture, Japan

TEL

079-437-3555

Homepage URL


Email

njapxblj@gmail.com


Sponsor or person

Institute

Junshin Hospital Clinical Neurosurgery Research Department

Institute

Department

Personal name



Funding Source

Organization

Medical Research Fund of Hyogo Medical Association

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Junshin Hospital Clinical Neurosurgery Research Department

Address

865-1 Befu, Befu-cho, Kakogawa City, Hyogo Prefect

Tel

079-437-3555

Email

njapxblj@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

198

Results

Comparison of baseline characteristics and clinical outcomes between patients with and without P2Y12 loading showed no significant differences in age, sex, or comorbidities. However, the loading group had significantly less motor worsening on day 7 (14.9% vs 28.9%, p=0.0243) and better outcomes on day 21 (74.3% vs 57.7%, p=0.0160).

Results date posted

2025 Year 07 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2023 Year 06 Month 30 Day

Date of IRB

2025 Year 07 Month 14 Day

Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2025 Year 07 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 14 Day

Last modified on

2025 Year 07 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066852